As of Jul 29
| +0.32 / +17.78%|
The 1 analysts offering 12-month price forecasts for Repros Therapeutics Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +135.85% increase from the last price of 2.12.
The current consensus among 3 polled investment analysts is to Hold stock in Repros Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.